Point State Capital LP Abbott Laboratories Transaction History

Point State Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $9.82 Million - $12 Million	-85,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $10.5 Million - $11.6 Million	-90,000 Reduced 51.43%	85,000 $10 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $52,895 - $62,265	500 Added 0.29%	175,000 $20.3 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $19 Million - $22.4 Million	174,500 New	174,500 $20.9 Million

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.